Please use this identifier to cite or link to this item:
Title: Molecular characterization of mutation associated with rifampicin and isoniazid resistance in <i style="">Mycobacterium tuberculosis</i> isolates
Authors: Negi, Sanjay Singh
Anand, Ranjana
Pasha, S T
Gupta, Sunil
Basir, Seemi Farhat
Khare, Shashi
Lal, Shiv
Keywords: Isoniazid
<i style="">Mycobacterium tuberculosis</i>
Issue Date: Jul-2006
Publisher: CSIR
Abstract: Nucleotide changes in catalase peroxidase (<i style="">Kat G</i>) gene and gene encoding the beta subunit of RNA polymerase (<i style="">rpo B</i>), responsible for isoniazid and rifampicin drug resistance were determined in the clinical isolates of <i style="">Mycobacterium tuberculosis</i> by PCR-RFLP, Line probe assay and DNA sequencing.<b style=""> </b>PCR-RFLP test was performed by HapII cleavage of an amplified fragment of <i style="">Kat G</i> gene to detect the transversion<b style=""> </b>315AGC→ACC(Ser→Thr) which is associated with INH drug resistance. The Line probe assay kit was evaluated to detect the mutation in 81bp RMP resistance determining region of <i style="">rpo B</i> gene associated with RMP drug resistance. These results were validated by DNA sequencing and drug susceptibility test.<b style=""> </b><i style="">Kat G</i> S 315 T mutation was found in 74.19% strains of <i style="">M. tuberculosis</i> from Delhi. This mutation was not found in any of the susceptible strains tested. The line probe assay kit<b style=""> </b>and DNA sequencing identified 18<b style=""> </b>isolates as RMP<b style=""> </b>resistant<b style=""> </b>with specific mutation,<b style=""> </b>while one of the RMP resistant strain was identified as RMP susceptible, with a concordance of 94.73% with the<b style=""> </b>phenotypic drug susceptibility result.<b style=""> </b>Majority (8 of 19, 42.1%) of resistant isolates involved base changes at codon 531 of<b style=""> </b><i style="">rpo B</i> gene.<b style=""> </b>Both PCR-RFLP and Line probe assay test can be used in many of the clinical microbiology laboratories for early detection of isoniazid and rifampicin drug resistance in clinical isolates of <i style="">M. tuberculosis</i>.
Description: 547-553
ISSN: 0975-1009 (Online); 0019-5189 (Print)
Appears in Collections:IJEB Vol.44(07) [July 2006]

Files in This Item:
File Description SizeFormat 
IJEB 44(7) 547-553.pdf272.32 kBAdobe PDFView/Open

Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.